29 /100
MEDIUM RISK
Score updated May 30, 2026

MNPR — Monopar Therapeutics Inc. Dilution Risk Tracker

Track MNPR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MNPR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration 15%
• Score climbed 7 points (worsening)
🔔 Track MNPR — Get forecast alerts →

💹 Market Data

Market Cap$435.71M
Shares Outstanding6.70M
Float4.13M
Cash$137.49M
Debt$230.4K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 32.8% shares (2025Q4 vs prior)
73 institutional holders · 5.76M shares
#1 JANUS HENDERSON GROUP PLC 1.32M shares
#2 RA CAPITAL MANAGEMENT, L.P. 667.2K shares
#3 ADAGE CAPITAL PARTNERS GP, L.L.C. 639.5K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.57M
Days to Cover8.1
% of Float38.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Mar 04, 2026
3 FORM3 Mar 04, 2026
4 INSIDER TRANSACTION Jan 30, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track MNPR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MNPR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for MNPR
📊 MNPR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MNPR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.